Bolt Biotherapeutics (BOLT) — Net Asset Quality Index
Bolt Biotherapeutics (BOLT) has a Net Asset Quality Index of 46.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $56.75 Million minus total liabilities of $30.24 Million yields net assets of $26.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Bolt Biotherapeutics liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bolt Biotherapeutics Net Asset Quality Index Over Time (2018–2025)
This chart shows how Bolt Biotherapeutics's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the index stands at 46.7%, representing net assets of $26.50 Million against total assets of $56.75 Million USD. See BOLT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Bolt Biotherapeutics (2018–2025)
The table below presents the year-by-year Net Asset Quality Index for Bolt Biotherapeutics from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BOLT market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.7% | $26.50 Million | $56.75 Million | $30.24 Million | ▼ -10.7 pp |
| 2024 | 57.4% | $57.20 Million | $99.63 Million | $42.43 Million | ▼ -13.1 pp |
| 2023 | 70.6% | $112.74 Million | $159.78 Million | $47.04 Million | ▼ -4.7 pp |
| 2022 | 75.3% | $171.51 Million | $227.81 Million | $56.30 Million | ▼ -6.0 pp |
| 2021 | 81.3% | $250.12 Million | $307.72 Million | $57.60 Million | ▲ +306.8 pp |
| 2020 | -225.5% | $-104.95 Million | $46.54 Million | $151.49 Million | ▼ -130.9 pp |
| 2019 | -94.6% | $-45.85 Million | $48.45 Million | $94.29 Million | ▲ +5.2 pp |
| 2018 | -99.8% | $-15.94 Million | $15.97 Million | $31.92 Million | — |